Taj Pharmaceuticals Limited
firmly believes that quality can not be talked
into a product,
but has to exist inherently. Its efforts towards
realizing world-class quality standards.
Taj Pharmaceuticals Limited’s
rapid growth and expansion in the international
and domestic markets led to the commencement
of a new formulations manufacturing facility
at Baddi, Himachal Pradesh, in the last quarter
of 2005-06. The upcoming facility, built
to world-class standards, will have capacity
to manufacture 2100 mn tablets and
shall become operational in JN 08.
Investment of around 2.35 million
USD is also being made to augment the API capacity
in Taj Pharmaceuticals Limited’s existing plant
at Maharashtra .This will ensure supply of quality
API for supply of formulations to the regulated
markets, especially USA and EU.
An organisations’ capabilities
and intent are strongly reflected in the product
it manufactures. In other words, the manufacturing
competencies and facilities echo truly, the
R&D extent and the ability to implement
it for the best of the market it targets.
Taj Pharmaceuticals Limited’s
manufacturing strengths have established it
as a producer of world-class generics, branded
generics and a major supplier of its range of
Active Pharmaceutical Ingredients. Taj Pharmaceuticals
Limited has world-class manufacturing facilities
in seven countries namely China, Ireland, India,
Malaysia, Nigeria, USA and Vietnam. Its overseas
facilities are designed to cater to the requirements
of the local regulatory bodies of that country
while the Indian facilities meet the requirements
of all International Regulatory Agencies. Some
of the agencies such as MCA-UK, MCC-Sout Africa,
FDA-USA and TGA-Australia, have audited and
approved Taj Pharmaceuticals Limited’s manufacturing
facilities for the compliance with international.
Good Manufacturing Practices and have registered
its products for safety, quality and efficacy.
Taj Pharmaceuticals Limited exports raw materials,
intermediates, prescription drugs, OTC products
and veterinary products. Taj Pharmaceuticals
Limited also offers technology for products
and processes. Technical know-how/fees received
during the year 2004-05 amounted to Rs.415 million.
Taj Pharmaceuticals Limited's manufacturing
facilities have been approved by the following
regulatory authorities:
|
|
